Design of Peptide Immunotherapies for MHC Class-II-Associated Autoimmune Disorders

被引:10
|
作者
Fridkis-Hareli, Masha [1 ]
机构
[1] ATR LLC, Worcester, MA 01606 USA
来源
CLINICAL & DEVELOPMENTAL IMMUNOLOGY | 2013年
关键词
AMINO-ACID COPOLYMERS; MYELIN BASIC-PROTEIN; T-CELL RESPONSES; REMITTING MULTIPLE-SCLEROSIS; ANTIGEN-PRESENTING CELLS; HISTOCOMPATIBILITY COMPLEX-MOLECULES; HLA-DR MOLECULES; RHEUMATOID-ARTHRITIS; GLATIRAMER ACETATE; EXPERIMENTAL ENCEPHALOMYELITIS;
D O I
10.1155/2013/826191
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Autoimmune disorders, that occur when autoreactive immune cells are induced to activate their responses against self-tissues, affect one percent of the world population and represent one of the top 10 leading causes of death. The major histocompatibility complex (MHC) is a principal susceptibility locus for many human autoimmune diseases, in which self-tissue antigens providing targets for pathogenic lymphocytes are bound to HLA molecules encoded by disease-associated alleles. In spite of the attempts to design strategies for inhibition of antigen presentation targeting the MHC-peptide/TCR complex via generation of blocking antibodies, altered peptide ligands (APL), or inhibitors of costimulatory molecules, potent therapies with minimal side effects have yet to be developed. Copaxone (glatiramer acetate, GA) is a random synthetic amino acid copolymer that reduces the relapse rate by about 30% in relapsing-remitting multiple sclerosis (MS) patients. Based on the elucidated binding motifs of Copaxone and of the anchor residues of the immunogenic myelin basic protein (MBP) peptide to HLA-DR molecules, novel copolymers have been designed and proved to be more effective in suppressing MS-like disease in mice. In this report, we describe the rationale for design of second-generation synthetic random copolymers as candidate drugs for a number of MHC class-II-associated autoimmune disorders.
引用
收藏
页数:9
相关论文
共 37 条
  • [31] Disease status in human and experimental arthritis, and response to TNF blockade, is associated with MHC class II invariant chain (CD74) isoform expression
    Clanchy, Felix I. L.
    Borghese, Federica
    Bystrom, Jonas
    Balog, Attila
    Penn, Henry C.
    Taylor, Peter W.
    Stone, Trevor A.
    Mageed, Rizgar O.
    Williams, Richard
    JOURNAL OF AUTOIMMUNITY, 2022, 128
  • [32] Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral IRF3 Modulates Major Histocompatibility Complex Class II (MHC-II) Antigen Presentation through MHC-II Transactivator-Dependent and -Independent Mechanisms: Implications for Oncogenesis
    Zuo, Jianmin
    Hislop, Andrew D.
    Leung, Carol S.
    Sabbah, Shereen
    Rowe, Martin
    JOURNAL OF VIROLOGY, 2013, 87 (10) : 5340 - 5350
  • [33] H2-M, a facilitator of MHC class II peptide loading, and its negative modulator H2-O are differentially expressed in response to proinflammatory cytokines
    Walter, W
    Scheuer, C
    Lingnau, K
    Reichert, TE
    Schmitt, E
    Loos, M
    Maeurer, MJ
    IMMUNOGENETICS, 2000, 51 (10) : 794 - 804
  • [34] Evaluation of a fit-for-purpose assay to monitor antigen-specific functional CD4+T-cell subpopulations in rheumatoid arthritis using flow cytometry-based peptide-MHC class-II tetramer staining
    Patel, Swati
    Ramnoruth, Nishta
    Wehr, Pascale
    Rossjohn, Jamie
    Reid, Hugh H.
    Campbell, Kim
    Nel, Hendrik J.
    Thomas, Ranjeny
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2022, 207 (01) : 72 - 83
  • [35] MHC class II alleles associated with Th1 rather than Th17 type immunity drive the onset of early arthritis in a rat model of rheumatoid arthritis
    Tuncel, Jonatan
    Haag, Sabrina
    Holmdahl, Rikard
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2017, 47 (03) : 563 - 574
  • [36] Experimental autoimmune encephalomyelitis induced in B6.C-H-2bm12 mice by myelin oligodendrocyte glycoprotein:: effect of MHC class II mutation on immunodominant epitope selection and fine epitope specificity of encephalitogenic T cells
    Mendel, I
    Gur, H
    de Rosbo, NK
    Ben-Nun, A
    JOURNAL OF NEUROIMMUNOLOGY, 1999, 96 (01) : 9 - 20
  • [37] Pro-IL-16 is Associated with MHC Class II-Mediated Negative Regulation of Mouse Resting B Cell Activation through MAP Kinases, NF-κB and Skp2-Dependent p27kip Regulation
    Yang, H. -Y.
    Kim, J.
    Kim, S. -H.
    Choe, C. -H.
    Jang, Y. -S.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2013, 77 (03) : 177 - 186